Highland Capital Management (Texas)’s Organogenesis Holdings ORGO Stock Holding History

Highland Capital Management (Texas)’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-77,282	Closed	-$784K	–	316
2018 Q3	$784K	Buy	77,282 +45,000	+139%	+$454K	0.04%	187
2018 Q2	$324K	Hold	32,282	–	–	0.02%	261
2018 Q1	$323K	Buy	+32,282	New	+$321K	0.02%	278
2017 Q3	–	Sell	-30,400	Closed	-$299K	–	334
2017 Q2	$299K	Buy	+30,400	New	+$299K	0.01%	246

Highland Capital Management (Texas)'s ORGO Position: Q4 2018 in Review

Highland Capital Management (Texas) sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 77,282 shares — an estimated $784K sold.

Highland Capital Management (Texas) first reported a position in ORGO in Q2 2017 and held it in 4 quarters. The position peaked at $784K in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Highland Capital Management (Texas) reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Highland Capital Management (Texas) sold 77,282 Organogenesis Holdings shares in Q4 2018, an estimated $784K.
Highland Capital Management (Texas) first reported a position in Organogenesis Holdings in Q2 2017 and held it in 4 quarters.
Highland Capital Management (Texas)'s Organogenesis Holdings position peaked at $784K in Q3 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2018, filed 13 Feb 2019.